14 January 2014 - Deborah Wilkes
Archived
Forest Laboratories is set to acquire privately-held speciality pharmaceutical company Aptalis for US$2.9 billion in cash.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.